BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia

by Katja Seipel, Basil Kopp, Ulrike Bacher, Thomas Pabst
Published 2021-02-01

Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia

by Katja Seipel, Karin Schmitter, Ulrike Bacher, Thomas Pabst
Published 2019-11-01

Autologous Transplantation for Older Adults with AML

by Beatrice U. Mueller, Katja Seipel, Ulrike Bacher, Thomas Pabst
Published 2018-09-01

Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia

by Katja Seipel, Carolyn Graber, Laura Flückiger, Ulrike Bacher, Thomas Pabst
Published 2021-07-01

(2<i>R</i>,3<i>S</i>)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia

by Jeffrey R. Idle, Katja Seipel, Ulrike Bacher, Thomas Pabst, Diren Beyoğlu
Published 2020-10-01

The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Ac...

by Katja Seipel, Miguel A. T. Marques, Corinne Sidler, Beatrice U. Mueller, Thomas Pabst
Published 2018-05-01

Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients

by Bianca R. Schnell, Katja Seipel, Ulrike Bacher, Barbara Jeker, Beatrice U. Mueller, Yara Banz, Urban Novak, Thomas Pabst
Published 2019-04-01

Life-Threatening Primary Varicella Zoster Virus Infection With Hemophagocytic Lymphohistiocytosis-Like Disease in GATA2 Haploinsufficiency Accompanied by Expansion of Double Negati...

by Seraina Prader, Matthias Felber, Matthias Felber, Benjamin Volkmer, Johannes Trück, Agnes Schwieger-Briel, Martin Theiler, Martin Theiler, Lisa Weibel, Lisa Weibel, Sophie Hambleton, Katja Seipel, Stefano Vavassori, Jana Pachlopnik Schmid, Jana Pachlopnik Schmid
Published 2018-12-01